Search research articles
Contact Us
Filters
Showing results (41-50 of 137) with videos related to
Page
of 14
Sort By:
Human Vaccines & Immunotherapeutics
|
December 16, 2025
Bacteriophages as vaccine platforms: Opportunities and challenges in translation
Wangxue Chen, Danielle L Peters, Serena Lam, et al.
Antimicrobial Agents and Chemotherapy
|
July 25, 2012
In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii
Louis de Léséleuc, Greg Harris, Rhonda KuoLee, et al.
Carbohydrate Research
|
February 4, 2009
The structure of the polysaccharide O-chain of the LPS from Acinetobacter baumannii strain ATCC 17961
Leann L MacLean, Malcolm B Perry, Wangxue Chen, et al.
Analytical Chemistry
|
September 14, 2010
Methylamidation for sialoglycomics by MALDI-MS: a facile derivatization strategy for both α2,3- and α2,6-linked sialic acids
Xin Liu, Hongyu Qiu, Rhonda Kuo Lee, et al.
World Journal of Gastroenterology
|
April 28, 2007
Intestinal M cells: the fallible sentinels?
Harvey Miller, Jianbing Zhang, Rhonda Kuolee, et al.
Microbial Pathogenesis
|
October 2, 2004
Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis
Wangxue Chen, Rhonda KuoLee, Hua Shen, et al.
Antimicrobial Agents and Chemotherapy
|
July 8, 2015
Protective effect of ginsenosides Rg1 and Re on lipopolysaccharide-induced sepsis by competitive binding to Toll-like receptor 4
Fei Su, Yin Xue, Yuemin Wang, et al.
Neurotoxicity Research
|
September 1, 2016
Sirtuin 5 is Anti-apoptotic and Anti-oxidative in Cultured SH-EP Neuroblastoma Cells
Fengyi Liang, Xie Wang, Suet Hui Ow, et al.
Vaccine
|
August 19, 2003
Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background
Wangxue Chen, Hua Shen, Ann Webb, et al.
Plos One
|
January 6, 2011
Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge
Girishchandra B Patel, Hongyan Zhou, Amalia Ponce, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 137) with videos related to
Sort By:
Page
of 14
Human Vaccines & Immunotherapeutics
|
December 16, 2025
Bacteriophages as vaccine platforms: Opportunities and challenges in translation
Wangxue Chen, Danielle L Peters, Serena Lam, et al.
Antimicrobial Agents and Chemotherapy
|
July 25, 2012
In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii
Louis de Léséleuc, Greg Harris, Rhonda KuoLee, et al.
Carbohydrate Research
|
February 4, 2009
The structure of the polysaccharide O-chain of the LPS from Acinetobacter baumannii strain ATCC 17961
Leann L MacLean, Malcolm B Perry, Wangxue Chen, et al.
Analytical Chemistry
|
September 14, 2010
Methylamidation for sialoglycomics by MALDI-MS: a facile derivatization strategy for both α2,3- and α2,6-linked sialic acids
Xin Liu, Hongyu Qiu, Rhonda Kuo Lee, et al.
World Journal of Gastroenterology
|
April 28, 2007
Intestinal M cells: the fallible sentinels?
Harvey Miller, Jianbing Zhang, Rhonda Kuolee, et al.
Microbial Pathogenesis
|
October 2, 2004
Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis
Wangxue Chen, Rhonda KuoLee, Hua Shen, et al.
Antimicrobial Agents and Chemotherapy
|
July 8, 2015
Protective effect of ginsenosides Rg1 and Re on lipopolysaccharide-induced sepsis by competitive binding to Toll-like receptor 4
Fei Su, Yin Xue, Yuemin Wang, et al.
Neurotoxicity Research
|
September 1, 2016
Sirtuin 5 is Anti-apoptotic and Anti-oxidative in Cultured SH-EP Neuroblastoma Cells
Fengyi Liang, Xie Wang, Suet Hui Ow, et al.
Vaccine
|
August 19, 2003
Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background
Wangxue Chen, Hua Shen, Ann Webb, et al.
Plos One
|
January 6, 2011
Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge
Girishchandra B Patel, Hongyan Zhou, Amalia Ponce, et al.
Page
of 14